Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04727996
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2021-01-23
Brief Title:
Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Organization Data
Organization:
Seoul National University Hospital
Class:
OTHER
Study ID:
H-2005-156-1126
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seoul National University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Do-Youn Oh
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Seoul National University Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| BeiGene | INDUSTRY |